SCHEMBL7512355

SCHEMBL7512355

CC(C)CCC[C@@H](C)[C@H]1CCC2=C3CCC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 3/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
ALDH1A1 P00352 1/20 0.56
MAPT P10636 1/20 0.56
ALOX15 P16050 1/20 0.56
RORC P51449 4/20 0.54
NR1I2 O75469 2/20 0.52
NR1H4 Q96RI1 2/20 0.51
ATP1A1 P05023 1/20 0.51
ATP1B1 P05026 1/20 0.51
ATP1A3 P13637 1/20 0.51
ATP1B2 P14415 1/20 0.51
ATP1A2 P50993 1/20 0.51
ATP1B3 P54709 1/20 0.51
FXYD2 P54710 1/20 0.51
ATP1A4 Q13733 1/20 0.51
LSS P48449 4/20 0.47
NPC1L1 Q9UHC9 2/20 0.46
LMNA P02545 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL337078 1.00 USP2 (0.56) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL5095966 1.00 USP2 (0.56) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL26642363 1.00 USP2 (0.56) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL4303282 1.00 USP2 (0.56) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL7249459 0.88 NR1I2 (0.50) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL4429572 0.88 NR1I2 (0.67) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL4429574 0.88 NR1I2 (0.67) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL31484563 0.88 NR1I2 (0.67) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL29935011 0.88 NR1I2 (0.67) USP2MEN1KMT2AALDH1A1MAPT
SCHEMBL7246364 0.87 NR1H4 (0.50) USP2MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020183283-A1 Meiosis regulating compounds FAARUP PETER (DK) 2002-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183283-A1 Meiosis regulating compounds SREBF2, SREBF1, TRIP13 USP2 1879/4885MEN1 2167/4885KMT2A 1254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.